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Dear editor:
Paracoccidioidomycosis is a rural and suburban endemic disease 
commonly manifesting as a pneumopathy of a chronic course, often associated 
with mucosal and skin lesions, and eventually with extra-pulmonary and 
disseminated lesions. The disease caused by Paracoccidioides brasiliensis is 
considered to be the most prevalent systemic fungal infection in Brazil and is 
present in many Latin American countries. It has been recently included in the 
list of neglected diseases whose impact on public health has not been quantified 
due to the lack of available data2. These diseases share some epidemiological, 
clinical and social characteristics that result in low visibility as a public health 
problem3. This is applicable to paracoccidioidomycosis and, with the exception 
of some measures in a few states, there are no governmental programs directed 
at this mycosis. About 100 years after the discovery of the disease caused by 
P. brasiliensis, there still is the need to implant an effective and permanent 
program for its prevention and diagnosis,  and for the provision of antifungal 
agents and assistance to patients with complications and sequelae. 
The fact that notification of cases of the disease is not obligatory is 
perhaps the main reason why paracoccidioidomycosis is neglected in the 
planning of public health in Brazil. However, asymptomatic infection with 
P. brasiliensis has been demonstrated in practically all Brazilian States by 
means of skin tests with paracoccidioidin. In some studies, the positivity of 
this test reached 60% among the individuals evaluated, being the number 
of individuals infected estimated at 10% of the Country population4. 
If this estimate is real, the prevalence of this fungal infection  would be 
comparable to that of Chagas’ disease in Latin America, exceeding that of 
other neglected diseases such as schistosomiasis and leishmaniasis2.
Regarding paracoccidioidomycosis-disease, series with large numbers 
of cases  receiving medical care at university hospitals have been reported 
over the last 20 years5,6. A single institution located in the Northeast of the 
State of São Paulo, the University Hospital of the Faculty of Medicine of 
Ribeirão Preto, University of São Paulo, receives approximately 40 new 
cases every year. Presumably, hundreds or even thousands of new annual 
cases of paracoccidioidomycosis may be occurring in Brazil.
This fungal disease requires prolonged treatment, commonly 
lasting more than one year. Relapses, complications and anatomical and 
functional sequelae occur in at least 20% of patients, among them the 
feared pulmonary fibrosis and subsequent respiratory insufficiency. As 
observed in other neglected diseases, patients with paracoccidioidomycosis 
have associated conditions aggravating their health such as alcoholism, 
smoking, malnutrition, tuberculosis, neoplasias, and AIDS7. At specialized 
centers, the need for a long or permanent patients follow-up generates 
a load of medical care at least five times higher than the number of new 
annual cases. The overall cost of treatment increases due to the need for 
various specialized physicians and other health professionals, as well as 
hospitalization for complementary therapeutics.
Although some effective antifungal agents are available for the clinical 
cure of paracoccidioidomycosis, the disease still causes deaths. The lethality 
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is higher in old studies, corresponding to 21.6%, 16.2% and 27%, respectively, 
at the end of treatment with sulfonamide drugs, amphotericin B or in a 
population of patients hospitalized in São Paulo, SP8. In two more recent 
studies, lethality was 7.6% and 9.3%, respectively, the latter among children5,9. 
Among 215 cases attended from 2000 to 2008 at the University Hospital of 
Ribeirão Preto, SP, lethality was close to 5% of cases. We may assume that 
all the cited rates  are falsely elevated since they refer to university hospitals 
which receive a greater proportion of severe cases of the mycosis.
In Brazil, there are registries of the mortality caused by the major 
systemic fungal disease. The mortality rate of paracoccidioidomycosis per 
1,000,000 inhabitants was 1.45 from 1980 to 1995 and 0.9-1.0 from 1996 to 
200610,11. This mycosis was responsible for most of the total number of deaths 
attributed to the seven major systemic fungal diseases. The distribution of 
deaths due to paracoccidioidomycosis according to geographic region and 
according to age and sex10,11 corresponds to the epidemiological data for 
cases of the disease, suggesting that the mortality registries are correct.
The mean annual number of deaths due to paracoccidioidomycosis 
in Brazil reached 168 during the 1996-2006 period11. Considering this 
mean value and a 5% mortality rate, it is possible to estimate the number 
of new annual cases of this mycosis in Brazil at 3,360. This number is 
close to the result obtained for the annual cases of the disease when 
an estimated incidence of 1/100,000 inhabitants/year is applied to the 
Brazilian population4. The expressive annual number of new patients, the 
large contingent of cases with a prolonged follow-up, plus the medical-
social characteristics mentioned above reveal the wide dimension of 
paracoccidioidomycosis as a public health problem in Brazil and emphasize 
its condition of neglected disease.
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